Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: Mid-season analysis 2012/13

J. McMenamin; N. Andrews; C. Robertson; D. M. Fleming; H. Durnall; B. von Wissmann; J. Ellis; A. Lackenby; S. Cottrell; B. Smyth; M. Zambon; C. Moore; J. M. Watson; R. G. Pebody

doi:10.2807/ese.18.05.20393-en

Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: Mid-season analysis 2012/13

J. McMenamin^*
, N. Andrews
, C. Robertson
, D. M. Fleming
, H. Durnall
, B. von Wissmann
, J. Ellis
, A. Lackenby
, S. Cottrell
, B. Smyth
, M. Zambon
, C. Moore
, J. M. Watson
, R. G. Pebody

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

Abstract

The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

Original language	English
Journal	Eurosurveillance
Volume	18
Issue number	5
DOIs	https://doi.org/10.2807/ese.18.05.20393-en
Publication status	Published - Jan 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2807/ese.18.05.20393-en

Cite this

McMenamin, J., Andrews, N., Robertson, C., Fleming, D. M., Durnall, H., von Wissmann, B., Ellis, J., Lackenby, A., Cottrell, S., Smyth, B., Zambon, M., Moore, C., Watson, J. M., & Pebody, R. G. (2013). Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: Mid-season analysis 2012/13. Eurosurveillance, 18(5). https://doi.org/10.2807/ese.18.05.20393-en

@article{4d4bc1240238469bb8a3a28931bd2a2d,

title = "Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: Mid-season analysis 2012/13",

abstract = "The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51\% (95\% confidence interval (CI): 27\% to 68\%); TIV adjusted VE against influenza A alone or influenza B alone was 49\% (95\% CI: -2\% to 75\%) and 52\% (95\% CI: 23\% to 70\%) respectively. Vaccination remains the best protection against influenza.",

author = "J. McMenamin and N. Andrews and C. Robertson and Fleming, \{D. M.\} and H. Durnall and \{von Wissmann\}, B. and J. Ellis and A. Lackenby and S. Cottrell and B. Smyth and M. Zambon and C. Moore and Watson, \{J. M.\} and Pebody, \{R. G.\}",

year = "2013",

month = jan,

doi = "10.2807/ese.18.05.20393-en",

language = "English",

volume = "18",

journal = "Eurosurveillance",

issn = "1025-496X",

publisher = "European Centre for Disease Prevention and Control (ECDC)",

number = "5",

}

McMenamin, J, Andrews, N, Robertson, C, Fleming, DM, Durnall, H, von Wissmann, B, Ellis, J, Lackenby, A, Cottrell, S, Smyth, B, Zambon, M, Moore, C, Watson, JM & Pebody, RG 2013, 'Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: Mid-season analysis 2012/13', Eurosurveillance, vol. 18, no. 5. https://doi.org/10.2807/ese.18.05.20393-en

TY - JOUR

T1 - Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom

T2 - Mid-season analysis 2012/13

AU - McMenamin, J.

AU - Andrews, N.

AU - Robertson, C.

AU - Fleming, D. M.

AU - Durnall, H.

AU - von Wissmann, B.

AU - Ellis, J.

AU - Lackenby, A.

AU - Cottrell, S.

AU - Smyth, B.

AU - Zambon, M.

AU - Moore, C.

AU - Watson, J. M.

AU - Pebody, R. G.

PY - 2013/1

Y1 - 2013/1

N2 - The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

AB - The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

UR - https://www.scopus.com/pages/publications/84873314142

U2 - 10.2807/ese.18.05.20393-en

DO - 10.2807/ese.18.05.20393-en

M3 - Article

AN - SCOPUS:84873314142

SN - 1025-496X

VL - 18

JO - Eurosurveillance

JF - Eurosurveillance

IS - 5

ER -

Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: Mid-season analysis 2012/13

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this